Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs Teradyne, Inc. (TER) Price & Performance

Novo Nordisk A/STrade
Teradyne, Inc.Trade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Teradyne, Inc. — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Teradyne, Inc. trades at $374.9 (market cap $52.25B). The key difference: Novo Nordisk A/S is far larger — about 4.2× Teradyne, Inc.'s market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.

NVOTER
Market Cap
$220.53B$52.25B
Sector
HealthTechnology
52-Week High
$71.70$483.84
52-Week Low
$35.29$90.15
Enterprise Value
$239.49B$52.08B
Dividend Yield
3.63%0.16%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Read more on TER